Review Article

A Concise Review of Ketogenic Dietary Interventions in the Management of Rare Diseases

Table 2

Efficacy and tolerability of different ketogenic diet regimens for children with intractable epilepsy in 5 randomized control trials.

AuthorYearStudy populationSample sizeIntervention of group 1Intervention of group 2Follow-up periodEfficacy of the dietAdverse events

1Bergqvist et al.2005Intractable epilepsy (1–14 years’ age group)Group1: n = 24
Group 2: n = 24
Fasting initiation of KDNonfasting gradual initiation of KD (ketogenic ratio from 1 : 1 to 4 : 1)3 monthsNo significant differenceLess weight loss, fewer and less severe episodes of hypoglycaemia, and fewer treatments for acidosis and dehydration in group 2
2Seo et al.2007Intractable childhood epilepsyGroup 1: n = 22
Group 2: n = 36
Diet with nonlipid : lipid ratio 4 : 1Diet with nonlipid : lipid ratio 3 : 13 monthsHigher in the 4 : 1 diet groupLess gastrointestinal symptoms in group 2
3Neal et al.2009Childhood intractable epilepsyGroup 1: n = 61
Group 2: n = 64
Classic dietMedium-chain triglyceride diet12 monthsNo significant differenceEquivalent except increased reports of lack of energy and vomiting in group 1
4Kang et al.2011Refractory infantile spasmsGroup 1: n = 16
Group 2: n = 19
Short-term (8 months) KDLong-term (>2 years) KDMore than 2 yearsNo significant differenceNo growth disturbance and osteopenia in group 1
5Raju et al.2011Childhood refractor epilepsy (6 months–5 years)Group 1: n = 19
Group 2: n = 19
Diet with nonlipid : lipid ratio 4 : 1Diet with nonlipid : lipid ratio 2.5 : 13 monthsNo significant differenceLess constipation, weight loss, and hospitalization for lower respiratory tract infections in group 2

KD: ketogenic diet.